SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 8 filers reported holding SINOVAC BIOTECH LTD in Q4 2023. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $0 | – | 40,000 | 0.0% | 0.00% | – |
| Q1 2024 | $0 | – | 40,000 | 0.0% | 0.00% | – |
| Q3 2023 | $0 | -100.0% | 40,000 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $259 | -99.9% | 40,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $259,000 | 0.0% | 40,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $259,000 | 0.0% | 40,000 | 0.0% | 0.00% | +100.0% |
| Q4 2021 | $259,000 | 0.0% | 40,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $259,000 | 0.0% | 40,000 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $259,000 | 0.0% | 40,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $259,000 | 0.0% | 40,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $259,000 | 0.0% | 40,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $259,000 | 0.0% | 40,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $259,000 | -50.0% | 40,000 | -50.0% | 0.00% | -33.3% |
| Q1 2020 | $518,000 | +100.0% | 80,000 | +100.0% | 0.00% | +50.0% |
| Q4 2019 | $259,000 | 0.0% | 40,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $259,000 | – | 40,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 5,900,000 | $38,173,000 | 3.58% |
| Neumann Advisory Hong Kong Ltd | 315,586 | $2,042 | 1.13% |
| Orbimed Advisors | 2,839,500 | $16,611,000 | 0.26% |
| Yorktown Management & Research Co Inc | 74,893 | $485,000 | 0.18% |
| Renaissance Technologies | 2,375,841 | $15,372,000 | 0.01% |
| Freedom Investment Management, Inc. | 20,759 | $134,000 | 0.01% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 68,732 | $445,000 | 0.00% |
| Financial Gravity Asset Management, Inc. | 183 | $1,000 | 0.00% |
| MORGAN STANLEY | 1,400 | $9,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 412 | $3,000 | 0.00% |